Services
FUNDRAISING
M&A
LICENSING
STRATEGIC CONSULTING
Transactions
Team
News
Contact
Life sciences
Acticor Biotech obtains “PRIME” status from the European Medicines Agency for glenzocimab in the treatment of stroke
Show more
Introductions : Acticor, 20 ME à lever
Show more
Bioadhesive Ophthalmics awarded as the best start-up 2021 by Neighborhood, VCLS Innovation Center and Voisin Consulting Life Sciences (VCLS)
Show more
Acticor Biotech Announces the Completion of Enrollment in its GARDEN clinical trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study
Show more
Acticor Biotech Announces the Completion of Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study
Show more
FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial
Show more